Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by KingWhatsion Jun 05, 2010 6:59am
373 Views
Post# 17161128

RE: A Missed Opportunity

RE: A Missed OpportunityLet me get this straight...

On June 3, dnaab23 writes

"Every time I e-mail Bob about the results we all are waiting on he has a different excuse. Anyone spoke with him in the past week?"

Next day on June 4, dnaab23 writes

"A missed opportunity to pick up shares at this price. I think we all will be smiling come next week. I had spoke with Bob on tuesday and he told me they had to bring in a service company from out of the country because there service rig could not handle the high pressure that this well had. And told me NR very soon so I exspect NR early part of the week."

Damn!

I thought this was a quality message board with people who were at least intelligent enough not to trip over their own BS. What you're saying is that they have spent millions drilling a hole, casing it, perforating it, only to find out in the final stage of testing that their equipment is inadequate. So is there oil spurting all over the place or what?

This "Bob" is going to wind up in jail if he keeps passing on all this insider information to every penny anti investor who calls or emails him.
Bullboard Posts